Marianne Späne to Leave Siegfried Management
The pharmaceutical service provider Siegfried has announced changes to its management team. Marianne Späne, who has been with the Swiss CDMO since 2004 and has held the position of Chief Business Officer since the beginning of 2020, is moving to the Board of Directors of the subsidiary Dinamiqs.
Späne will leave the Executive Board on July 31, 2025 and support his designated successor, Peter Freisler, during a transition phase. Späne will become a member of the Board of Directors of Dinamiqs on January 1, 2026.
Peter Freisler will join Siegfried as Chief Business Officer and member of the Executive Board on August 1, 2025. Freisler comes from Evonik, where he has held various management positions over the past ten years, most recently as Global Vice President Sales and Services for the Health Care Division. He holds an MBA from Justus Liebig University Giessen and a Master of Arts in Economics from the University of Milwaukee-Wisconsin, USA.
Marcel Imwinkelried, CEO of Siegfried, said: "With his extensive experience in business development across different regions and markets, Peter Freisler will immediately be able to contribute to growth and further accelerate the implementation of our go-to-market strategy within EVOLVE +. Marianne Späne is a very valuable colleague who has contributed significantly to Siegfried's success over many years. We are very pleased that Marianne will remain associated with Siegfried as a member of Dinamiqs' Board of Directors. Her deep expertise and many years of experience in the CDMO industry will be a great asset to DINAMIQS as we look to the next phase of growth."
